Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0310505 PROSTAMIDES FOR ENHANCEMENT OF LEPTIN PRODUCTION
Prostamides such as bimatoprost and its pro-drugs for enhancement of leptin production and appetite suppression.
2016/0310504 INJECTABLE MIRTAZAPINE FOR TREATING APPETITE LOSS AND NUTRITIONAL DISORDERS IN CATS
Described herein is a method of administering mirtazapine via the parenteral route to treat the decrease or loss of appetite and/or other disorders induced by...
2016/0310503 Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising...
2016/0310502 NOVEL METHODS
The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms...
2016/0310501 GABAPENTINOIDS AND SIGMA RECEPTOR LIGANDS COMBINATIONS
The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Gabapentinoid, a medicament comprising said active...
2016/0310500 SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), a...
2016/0310499 Highly Active Anti-Neoplastic and Anti-Proliferative Agents
This invention is in the area of improved compounds and methods for treating selected cancers and hyperproliferative disorders.
2016/0310498 Axillary Transdermal Compound Delivery System
A deodorant stick drug delivery system has one or more hydrophilic carriers, water, one or more gelling agents, an active ingredient, and a solvent. The active...
2016/0310497 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS
The present application provides substituted purine derivatives and related compounds of the formulas shown. These compounds are useful as inhibitors of HSP90,...
2016/0310496 NOVEL TETRAHYDROPYRIDOPYRIMIDINE COMPOUND OR SALT THEREOF
A method for inhibiting androgen activity, including administering an effective amount of a tetrahydropyridopyrimidine compound of formula (I) or a...
2016/0310495 PHARMACEUTICAL COMPOSITIONS OF PEMETREXED
A pharmaceutical composition of Pemetrexed represented by formula (I), which is a liquid ready to use solution formulation or a lyophilized pharmaceutical...
2016/0310494 HETEROCYCLIC COMPOUND
Provided is a compound useful for the prophylaxis or treatment of cancer. The present invention relates to a compound represented by formula (I): ##STR00001## ...
2016/0310493 USE OF PEMIROLAST IN THE TREATMENT OF ACUTE ASTHMA
According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as...
2016/0310492 Marker for Cancer Prognosis and Methods Related Thereto
The present invention is related to the novel discovery that HIF-2.alpha., but not HIF-1.alpha., selectively regulates adenosine A.sub.2A receptor in...
2016/0310491 SELECTIVE CALCIUM CHANNEL ANTAGONISTS
The present invention relates to compositions and methods for the treatment and/or prevention of neurodegenerative disorders, e.g., Parkinson's disease (PD)....
2016/0310490 SYK INHIBITORS
The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and...
2016/0310489 CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS
The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically...
2016/0310488 Use of an Opioid Receptor Antagonist with Kappa-Activity and Vortioxetine for Treatment of Depressive Disorder...
The present invention relates to an opioid antagonist with .kappa.-activity for use in treatment of depressive disorder with melancholic features. The...
2016/0310487 TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
A tamper-resistant pharmaceutical dosage form comprising a multitude of particles which comprise a pharmacologically active compound, a polyalkylene oxide, and...
2016/0310486 TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES AND A MATRIX
A tamper-resistant pharmaceutical dosage form comprising two pharmacologically active ingredients, wherein the dosage form provides under in vitro conditions...
2016/0310485 COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS
The present application relates to compositions, kits, uses, systems and methods of using naltrexone and bupropion, or pharmaceutically acceptable salts...
2016/0310484 TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT
The present invention relates to improved compositions and methods for the treatment or prevention of various diseases, including forms of depression,...
2016/0310483 PYRIDINYL AND FUSED PYRIDINYL TRIAZOLONE DERIVATIVES
Disclosed are compounds of Formula 1, ##STR00001## or pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are defined in...
2016/0310482 METHOD FOR TREATING GEFITINIB RESISTANT CANCER
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for...
2016/0310481 LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS
This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the...
2016/0310480 THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution...
2016/0310479 METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET
An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a...
2016/0310478 MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES
A particulate, pH-independent, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a...
2016/0310477 CANCER TREATMENTS USING COMBINATIONS OF MEK TYPE 1 AND ERK INHIBITORS
The present invention provides, inter alia, methods, kits, and pharmaceutical compositions for treating or ameliorating the effects of a cancer in a subject in...
2016/0310476 CANCER TREATMENT USING COMBINATIONS OF ERK AND RAF INHIBITORS
The present invention provides, inter alia, methods of treating or ameliorating the effects of a cancer in a subject. The methods include administering to the...
2016/0310475 PROTEIN TYROSINE PHOSPHATASE INHIBITOR, PREPARATION METHOD AND USES THEREOF
Disclosed in the present invention is a protein tyrosine phosphatase inhibitor. The preparation method therefor is: extracting the crude product from the...
2016/0310474 N-BIARYLAMIDES
The invention relates to N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of...
2016/0310473 COMBINATION THERAPIES FOR TREATMENT OF LAMINOPATHIES, CELLULAR AGING, AND ATHEROSCLEROSIS
Provided herein are combination therapies for the treatment of progeroid diseases and conditions, cellular aging, bone diseases, and cardiovascular diseases....
2016/0310472 PHARMACEUTICAL COMPOSITIONS COMPRISING SULBACTAM AND IMIPENEM
Pharmaceutical compositions comprising sulbactam or a pharmaceutically acceptable derivative thereof, and imipenem or a pharmaceutically acceptable derivative...
2016/0310471 NOVEL GLP-1 RECEPTOR STABILIZERS AND MODULATORS
Compounds that bind the glucagon-like peptide 1 (GLP-1) receptor, methods of their synthesis, methods of their therapeutic and/or prophylactic use, and methods...
2016/0310470 ORODISPERSIBLE TABLETS
This invention relates to a an orally disintegrating tablet obtainable by direct compression of a dry powdered mixture, said mixture comprising up to 15% by...
2016/0310469 NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY
The present invention is made for the purpose of improving beef quality and upgrading its fat marbling standard (which is called beef marbling standard, or...
2016/0310468 SUBSTITUTED IMIDAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are...
2016/0310467 ONDANSETRONE TO REVERSAL OF THE SOFT TISSUE ANESTHESIA
Invention is about the ondansetrone hydrochloride which is used in the reversal of the effect of the local anesthesia of the soft tissues in a short time...
2016/0310466 COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM
The present invention is directed to compositions and methods for treating ocular conditions, including presbyopia, mild hyperopia, irregular astigmatism,...
2016/0310465 SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITIORS
The present invention relates to substituted indazole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases...
2016/0310464 METHOD OF DOSING AND USE OF SOFT ANTICHOLINERGIC ESTERS
A method of treating hyperhidrosis in a mammalian subject comprising: a) providing a composition comprising a pharmaceutically acceptable vehicle and from about...
2016/0310463 LIQUID STATIN FORMULATION
The present invention relates to compositions and methods for liquid statin products suitable for use in a person or animal. The invention provides stable...
2016/0310462 PALYTOXYN, ITS MEDICAL USE AND PROCESS FOR ITS ISOLATION
A pharmaceutical composition intended for use in the prevention and/or treatment of leukaemia in a subject, the composition includes palytoxin (PLTX) and a...
2016/0310461 Sulfamate Derivative Compound for Use in Preventing or Treating Epilepsy
The present invention relates to a pharmaceutical composition for treating or preventing epilepsy containing a sulfamate derivative compound and/or...
2016/0310460 ITCH SUPPRESSION BY FUCOXANTHIN
The present invention provides a method of suppressing mast cell differentiation and/or itch in the skin of a subject, comprising topically administering to...
2016/0310459 Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias
The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the...
2016/0310458 COMPOUNDS USEFUL FOR INCREASING NEUROGENESIS IN NEURAL TISSUE
The invention described herein is directed to the use of acetyl L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for...
2016/0310457 PHARMACEUTICAL COMPOSITIONS COMPRISING DIMETHYL FUMARATE
Pharmaceutical compositions are described comprising (a) dimethyl fumarate, (b) a diluent selected from monosaccharides, disaccharides, starch, and starch...
2016/0310456 COMPOSITIONS AND METHODS FOR USING SAME FOR REDUCING LEVELS OF ARACHIDONIC ACID IN TISSUE HAVING UNDERGONE AN...
This invention relates to compositions for reducing levels of arachidonic acid (omega-6) found at the cellular level in tissue after surgery, wherein the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.